Compare GNTX & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GNTX | MIR |
|---|---|---|
| Founded | 1974 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Industrial Machinery/Components |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 5.7B |
| IPO Year | N/A | N/A |
| Metric | GNTX | MIR |
|---|---|---|
| Price | $23.93 | $27.03 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 7 |
| Target Price | ★ $29.00 | $28.29 |
| AVG Volume (30 Days) | ★ 2.2M | 2.1M |
| Earning Date | 01-30-2026 | 02-10-2026 |
| Dividend Yield | ★ 2.01% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.70 | 0.10 |
| Revenue | ★ $2,431,504,922.00 | $902,300,000.00 |
| Revenue This Year | $11.92 | $8.75 |
| Revenue Next Year | $4.87 | $23.17 |
| P/E Ratio | ★ $14.09 | $265.31 |
| Revenue Growth | 3.00 | ★ 7.82 |
| 52 Week Low | $20.28 | $12.00 |
| 52 Week High | $29.38 | $30.28 |
| Indicator | GNTX | MIR |
|---|---|---|
| Relative Strength Index (RSI) | 51.09 | 64.31 |
| Support Level | $23.35 | $26.01 |
| Resistance Level | $24.92 | $27.40 |
| Average True Range (ATR) | 0.56 | 0.88 |
| MACD | -0.02 | 0.36 |
| Stochastic Oscillator | 45.19 | 90.75 |
Gentex was founded in 1974 to produce smoke-detection equipment. The company sold its first glare-control interior mirror in 1982 and its first model using electrochromic technology in 1987. Automotive revenue is about 98% of total revenue. The company is constantly developing new applications for the technology to remain on top. Sales in 2024 totaled about $2.3 billion with 47.7 million mirrors shipped. The unit mix breaks out as 63% interior and 37% exterior, versus 31% exterior in 2019. The company is based in Zeeland, Michigan.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.